FHIR IG analytics| Package | test.fhir.onc.ctm |
| Resource Type | MedicationAdministration |
| Id | MedicationAdministration-cancer-related-medication-admin-cyclophosphamide-jenny-m.json |
| FHIR Version | R4 |
No resources found
No resources found
No narrative content found in resource
{
"resourceType": "MedicationAdministration",
"id": "cancer-related-medication-admin-cyclophosphamide-jenny-m",
"meta": {
"profile": [
"http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
"valueCodeableConcept": {
"coding": [
{
"code": "373808002",
"system": "http://snomed.info/sct",
"display": "Curative - procedure intent (qualifier value)"
}
]
}
}
],
"status": "completed",
"category": {
"coding": [
{
"code": "outpatient",
"system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category"
}
]
},
"medicationCodeableConcept": {
"coding": [
{
"code": "3002",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "cyclophosphamide"
}
]
},
"subject": {
"reference": "Patient/cancer-patient-jenny-m"
},
"effectiveDateTime": "2018-04-22",
"performer": [
{
"actor": {
"reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
}
}
],
"reasonReference": [
{
"reference": "Condition/primary-cancer-condition-jenny-m"
}
],
"note": [
{
"authorReference": {
"reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
},
"time": "2018-04-22",
"text": "cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."
}
],
"dosage": {
"route": {
"coding": [
{
"code": "47625008",
"system": "http://snomed.info/sct",
"display": "Intravenous route (qualifier value)"
}
]
},
"dose": {
"value": 932.59,
"code": "mg",
"system": "http://unitsofmeasure.org",
"unit": "mg"
}
}
}